Occurrence of tinnitus and peripheral sensory neuropathy in women during chemotherapy treatment of breast cancer
Objective: To analyze the occurrence of tinnitus and peripheral sensory neuropathy in women during breast cancer chemotherapy. Methods: This is a retrospective analytical study with a quantitative approach, performed in medical records of an oncology outpatient service between February 2014 and February 2015, using the toxicities scores of Common Terminology Criteria for Adverse Events (CTCAE). Results: Considering 181 patients with breast cancer who met the inclusion criteria, 49.2% reported tinnitus at some point of the treatment, while 65.1% peripheral sensory neuropathy. In both conditions, the predominant severity score was grade 1, with frequencies of 23.8% and 33.1%, respectively. A significant, positive and weak correlation was observed between the severity of tinnitus and peripheral sensory neuropathy (ρ = 0.325 and p = 0.001), as well as very weak between the number of complete cycles of chemotherapy and tinnitus (ρ = 0.195 and p = 0.009) and neuropathy peripheral sensory (ρ = 0.237 and p = 0.002). Conclusions: Tinnitus and peripheral sensory neuropathy were frequent toxicities during chemotherapy treatment of breast cancer, and both manifested with low severity/functional impact in most participants..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:11 |
|---|---|
| Enthalten in: |
Revista Ciências em Saúde - 11(2021), 1, Seite 69-79 |
| Sprache: |
Englisch ; Portugiesisch |
|---|
| Beteiligte Personen: |
Simone Yuriko Kameo [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Breast neoplasms |
|---|
| doi: |
10.21876/rcshci.v11i1.1089 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ057005036 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ057005036 | ||
| 003 | DE-627 | ||
| 005 | 20230502135433.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230227s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.21876/rcshci.v11i1.1089 |2 doi | |
| 035 | |a (DE-627)DOAJ057005036 | ||
| 035 | |a (DE-599)DOAJbff2dcf705ea4a76b10d5f54318b29b0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a por | ||
| 050 | 0 | |a RT1-120 | |
| 050 | 0 | |a R5-920 | |
| 100 | 0 | |a Simone Yuriko Kameo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Occurrence of tinnitus and peripheral sensory neuropathy in women during chemotherapy treatment of breast cancer |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Objective: To analyze the occurrence of tinnitus and peripheral sensory neuropathy in women during breast cancer chemotherapy. Methods: This is a retrospective analytical study with a quantitative approach, performed in medical records of an oncology outpatient service between February 2014 and February 2015, using the toxicities scores of Common Terminology Criteria for Adverse Events (CTCAE). Results: Considering 181 patients with breast cancer who met the inclusion criteria, 49.2% reported tinnitus at some point of the treatment, while 65.1% peripheral sensory neuropathy. In both conditions, the predominant severity score was grade 1, with frequencies of 23.8% and 33.1%, respectively. A significant, positive and weak correlation was observed between the severity of tinnitus and peripheral sensory neuropathy (ρ = 0.325 and p = 0.001), as well as very weak between the number of complete cycles of chemotherapy and tinnitus (ρ = 0.195 and p = 0.009) and neuropathy peripheral sensory (ρ = 0.237 and p = 0.002). Conclusions: Tinnitus and peripheral sensory neuropathy were frequent toxicities during chemotherapy treatment of breast cancer, and both manifested with low severity/functional impact in most participants. | ||
| 650 | 4 | |a breast neoplasms | |
| 650 | 4 | |a drug-related side effects and adverse reactions | |
| 650 | 4 | |a drug therapy | |
| 650 | 4 | |a ototoxicity | |
| 650 | 4 | |a tinnitus | |
| 653 | 0 | |a Nursing | |
| 653 | 0 | |a Medicine (General) | |
| 700 | 0 | |a Ricardo Barbosa-Lima |e verfasserin |4 aut | |
| 700 | 0 | |a Josilene Luciene Andrade |e verfasserin |4 aut | |
| 700 | 0 | |a Bruno Ferreira Amorim |e verfasserin |4 aut | |
| 700 | 0 | |a Glebson Moura Silva |e verfasserin |4 aut | |
| 700 | 0 | |a Pabliane Matias Lordelo Marinho |e verfasserin |4 aut | |
| 700 | 0 | |a Namie Okino Sawada |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Revista Ciências em Saúde |d Hospital de Clínicas de Itajubá, 2017 |g 11(2021), 1, Seite 69-79 |w (DE-627)DOAJ000018597 |x 22363785 |7 nnns |
| 773 | 1 | 8 | |g volume:11 |g year:2021 |g number:1 |g pages:69-79 |
| 856 | 4 | 0 | |u https://doi.org/10.21876/rcshci.v11i1.1089 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/bff2dcf705ea4a76b10d5f54318b29b0 |z kostenfrei |
| 856 | 4 | 0 | |u http://186.225.220.186:7474/ojs/index.php/rcsfmit_zero/article/view/1089 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2236-3785 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 912 | |a SSG-OLC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 11 |j 2021 |e 1 |h 69-79 | ||